Work

Anti–PD-1 immunotherapy with chemotherapy for poorly chemo-responsive thyroid and salivary gland tumors: The iPRIME study.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.6124

Authors: Faith Abodunrin, Theodore Karrison, Ari Joseph Rosenberg, Jeffery Chin, Rachel Hartnett, Jeffrey Minehart, Andrew Harding, Aditya Juloori, Chih-Yi Liao, Rohan Reddy Katipally, Sara Kochanny, Nnamdi Joseph Omenuko, Evgeny Izumchenko, Nicole Cipriani, Nishant Agrawal, Daniel J. Haraf, Everett E. Vokes, Alexander T. Pearson

Institutions: University of Chicago, Rosalind Franklin University of Medicine and Science, University of Chicago Medical Center, East Tennessee State University

Language: English

Topic: Salivary Gland Tumors Diagnosis and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162489790

Cites:

Cited by:

Related to: